SCHEMBL4556004

SCHEMBL4556004

O=S(=O)(c1cc(F)ccc1F)N1CCCCCC1

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.71
KDM4E B2RXH2 1/20 0.66
NPC1 O15118 1/20 0.62
RAB9A P51151 1/20 0.62
TSHR P16473 6/20 0.58
ALDH1A1 P00352 4/20 0.58
POLB P06746 1/20 0.57
CYP3A4 P08684 2/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
ALOX15 P16050 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
MAPT P10636 4/20 0.53
TP53 P04637 3/20 0.53
HTT P42858 2/20 0.50
MITF O75030 1/20 0.50
LMNA P02545 1/20 0.50
GAA P10253 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4554020 0.86 KDM4E (0.61) PKMKDM4ENPC1RAB9ATSHR
SCHEMBL20595150 0.86 KDM4E (0.61) PKMKDM4ENPC1RAB9ATSHR
SCHEMBL15872028 0.83 TSHR (0.64) PKMKDM4ETSHRALDH1A1POLB
SCHEMBL4166290 0.83 ALDH1A1 (0.67) KDM4ERAB9ATSHRALDH1A1POLB
SCHEMBL15651359 0.81 KDM4E (0.60) PKMKDM4ENPC1RAB9ATSHR
SCHEMBL31429867 0.81 GAA (0.61) PKMNPC1RAB9ATSHRALDH1A1
SCHEMBL24711661 0.81 PKM (0.64) PKMKDM4ENPC1RAB9ATSHR
SCHEMBL14200104 0.81 LMNA (0.60) PKMKDM4ETSHRALDH1A1CYP3A4
SCHEMBL28254881 0.80 TSHR (0.55) PKMKDM4ETSHRALDH1A1POLB
SCHEMBL12778087 0.80 KDM4E (0.58) PKMKDM4ENPC1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134714-A1 TRICYCLIC ISOQUINOLINE DERIVATIVES FOR TREATMENT OF OBESITY Biovitrum AB (publ) (SE) 2009-12-23 EP disclosed
WO-2008110598-A1 TRICYCLIC ISOQUINOLINE DERIVATIVES FOR TREATMENT OF OBESITY BIOVITRUM AB (PUBL) (SE) 2008-09-18 WO disclosed